Skip to main content
. Author manuscript; available in PMC: 2015 Jan 17.
Published in final edited form as: Circ Res. 2014 Jan 17;114(2):368–378. doi: 10.1161/CIRCRESAHA.113.300536

Table 1. Cardiac phenotype of Akt and Sirtuins knockout and transgenic mice.

Mice genotype Cardiac Phenotype Refs
Akt1-KO Akt1-KO mice show reduced cardiac muscle mass and display defects in physiological growth. Mice develop an exacerbated form of cardiac hypertrophy when subjected to pressure overload. 25-27
Akt2-KO Akt2-deficiency does not affect cardiac mass, but induces insulin resistance, mitochondrial and cardiac contractile dysfunction. Akt2-KO mice are more sensitive to myocardial injury as evidenced by increased myocyte death and inflammatory cardiomyopathy. 25, 28-32
Akt3-KO No obvious cardiac phenotype noted. 33
Akt1-transgenic Cardiomyocyte specific Akt expression increases myocyte size and induces cardiac hypertrophy. But Akt1 transgenic mice are protected from injury caused by transient cardiac ischemia. 34-39
Akt3-transgenic Cardiac-specific over expression of Akt3 induces cardiac hypertrophy, and contractile dysfunction together with increasing susceptibility of the heart to cardiac injury. 40
Nuclear-Akt1 transgenic Transgenic hearts exhibit increased number of smaller cardiomyocytes that relates with cardiomyocyte survival and enhanced contractile function. 41, 42
SIRT1-KO Whole-body SIRT1-deficient mice show reduced heart size and are resistant to develop cardiac hypertrophy. Contrary, cardiomyocyte specific SIRT1-KO mice do not show any cardiac abnormalities at basal conditions; however, they are more susceptible to ischemic injury. Partial deficiency of SIRT1 attenuated pressure overload induced cardiac hypertrophy and failure. 43-45
SIRT2-KO No basal cardiac abnormalities are noted, but SIRT2-KO mice are protected from ischemic injury due to attenuated programmed apoptosis in the heart. 46
SIRT3-KO SIRT3-KO mice show no basal cardiac abnormalities at birth, but develop hypertrophy, fibrosis and contractile dysfunction with age. SIRT3 deficient mice are highly susceptible to cardiac hypertrophic stimuli. 47-49
SIRT6-KO Massive concentric cardiac hypertrophy and heart failure were observed in the whole-body and cardiac-specific SIRT6 deficient mice. 50
SIRT7-KO SIRT7-deficiency induces spontaneous cardiac hypertrophy and inflammatory cardiomyopathy in mice. 51
SIRT1-transgenic Low to moderate over expression of SIRT1 attenuates age-dependent decline in cardiac functions in mice. However, high level of SIRT1 expression induces cardiac hypertrophy and heart failure. 43, 44, 52
SIRT3-transgenic Cardiac specific over expression of SIRT3 protects the heart from hypertrophic stimuli by preserving mitochondrial function. 48
SIRT6-transgenic Cardiac specific over expression of SIRT6 protects the heart from hypertrophic stimuli by blocking activation of Akt signaling at the level of chromatin. 50